If you are a resident of Vermont who has been prescribed Wegovy for weight management and are experiencing adverse side effects, know that you’re not navigating this complex situation by yourself. Our Vermont-based firm has noticed a growing trend of Vermonters facing complications after using Wegovy (semaglutide). For those deliberating the legal ramifications associated with Wegovy within Vermont, our experienced pharmaceutical liability lawyers are at your service. Teaming up with an attorney well-versed in Wegovy-related matters is crucial. Contact us for comprehensive legal guidance tailored to your particular situation.

Wegovy, with semaglutide as its primary component, has secured FDA approval and is predominantly prescribed to address obesity. It acts by imitating a hormone that regulates appetite in the brain. As a member of the glucagon-like peptide-1 (GLP-1) receptor agonists group, it’s also prescribed for diabetes care.

The use of semaglutide in weight management has drawn considerable focus. Brands like Wegovy, Ozempic, Rybelsus, Trulicity, Mounjaro, and Saxenda, initially developed for diabetes, are now hailed as pioneering weight loss tools. While these medications mainly cater to those battling obesity, an increasing number of non-obese Vermonters are turning to them for weight control. Recognizing the inherent risks of any medication is vital. Adverse reactions to Wegovy are escalating, and Vermont is no outlier.


Novo Nordisk, originating from Denmark, is the manufacturer of Wegovy. For Vermonters who’ve suffered negative consequences from its use, contemplating legal action against Novo Nordisk may be a wise decision. Potential legal paths could include product liability claims, addressing concerns like negligence, inadequate risk disclosure, production flaws, or other pertinent legal standards consistent with Vermont’s legal code. If you or someone you know has been affected by Wegovy and are considering legal action against its producer, fill out the form below to receive a free case evaluation and see if you have a case:

  • MM slash DD slash YYYY
    Estimate date if insure


The prospect of participating in a Wegovy class action might appeal to some Vermonters. Yet, when grappling with profound health challenges, pursuing an individual claim might be more strategic within Vermont’s legal parameters. Such an approach may expedite resolutions and offer enhanced compensation.


For those using Wegovy and consistently dealing with gastrointestinal problems like nausea, bloating, or abdominal discomfort, it’s imperative to consult a healthcare expert about the potential of gastroparesis or delayed gastric emptying. The FDA has underscored numerous grave health risks. Here’s an overview of the primary potential side effects associated with Wegovy (semaglutide):

  • Gastroparesis: Often termed “stomach paralysis,” this ailment obstructs the stomach’s ability to process food.
  • Pancreatitis: Denotes the inflammation of the pancreas and necessitates prompt medical intervention. Symptoms may encompass severe abdominal pain and nausea.
  • Gallbladder Complications: Those taking Wegovy could face an elevated risk of gallstones or gallbladder inflammation, identifiable by symptoms such as sharp abdominal pain or skin hue alterations.
  • Kidney Issues: Initial research suggests a tentative correlation between semaglutide and kidney malfunctions, manifesting in symptoms from reduced appetite to compromised kidney functionality.
  • Hypoglycemia (Low Blood Sugar): Diabetics on certain regimens may observe that Wegovy significantly reduces blood sugar, leading to symptoms like disorientation or an accelerated heartbeat.
  • Allergic Manifestations: A subset of users may present severe allergic reactions to semaglutide, marked by symptoms like skin flare-ups, swelling, or breathing challenges.
  • Thyroid Tumors: Due to its categorization, there are concerns about Wegovy being linked to an increased occurrence of thyroid C-cell tumors, inclusive of conditions like medullary thyroid carcinoma.
  • Worsening of Diabetic Retinopathy: Consumption of Wegovy may exacerbate existing diabetic visual conditions.
  • Ophthalmic Issues: Such as altered vision or other eye-related troubles.

For Vermonters considering legal avenues concerning Wegovy, we urge you to connect with our proficient Vermont legal team to assess potential case eligibility.

Vermont Hospitals:

Hospital Name City
Brattleboro Memorial Hospital Brattleboro
Central Vermont Medical Center Berlin
Northwestern Medical Center Saint Albans
Rutland Regional Medical Center Rutland
Southwestern Vermont Medical Center Bennington
The University of Vermont Medical Center Burlington
White River Junction VA Medical Center White River Junction